바이오마커 시장 규모는 향후 몇 년동안 연평균 14.7%의 성장률(CAGR)로 2029년까지 1,351억 4,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 질병의 조기 발견 및 예방에 대한 관심 증가, 종양학 및 면역 요법에서 바이오마커의 확대, 정밀의료 이니셔티브에 대한 투자 증가, 비침습적 바이오마커 검출 방법으로서 액체 생검의 부상, 신약 개발 및 약물 개발에서 바이오마커에 대한 선호도 증가에 기인합니다. 기인하고 있습니다. 예측 기간 동안 주요 동향으로는 다중 바이오마커 패널의 개발, 엑소좀 기반 바이오마커의 등장, 현장 진료 바이오마커 검사의 채택, 바이오마커 연구에서의 실제 데이터 통합, 마이크로바이옴 기반 바이오마커의 탐색 등이 있습니다.
심장 질환 증가는 예측 기간 동안 바이오마커 시장의 성장을 가속할 것으로 예상됩니다. 심장병 환자에 대한 바이오마커의 사용은 지난 몇 년동안 비약적으로 증가하고 있습니다. 현재, 나트륨 이뇨 펩타이드는 가장 많이 사용되는 바이오마커로 심부전 환자의 진단에 도움이 되고 있습니다. 심부전 진단에는 고감도 C 반응성 단백질을 이용한 순환기 바이오마커 등이 사용됩니다. 심장병은 미국 내 대부분의 인종 및 민족의 주요 사망 원인 중 하나입니다. 심장질환 증가는 바이오마커에 대한 수요를 촉진할 것으로 보입니다. 예를 들어, 2022년 8월 미국 비영리 의료단체인 미국심장학회(American College of Cardiology)가 발표한 보고서에 따르면, 미국에서는 2025년부터 2060년 사이에 4가지 심혈관 위험인자가 모두 증가할 것으로 예측됩니다. 가장 높은 증가율은 당뇨병(39.3% 증가, 5,500만 명), 지질 이상증(27.6% 증가, 1억 2,600만 명), 고혈압(25.1% 증가, 1억 6,200만 명), 비만(18.3% 증가, 1억 2,600만 명) 순입니다. 또한 심혈관질환 증가율이 가장 클 것으로 예측된 것은 뇌졸중(33.8% 증가한 1,500만 명)과 심부전(33.4% 증가한 1,300만 명)이며, 허혈성심장질환(30.7% 증가한 2,900만 명)과 심장마비(16.9% 증가한 1,600만 명)가 그 뒤를 이었습니다. 심장 질환과 심장 사망이 증가함에 따라 바이오마커의 성장도 증가합니다.
고령 인구 증가는 향후 바이오마커 시장의 성장을 견인할 것으로 예상됩니다. 고령자 인구는 18-64세 취업자 중 65세 이상 인구가 차지하는 비율을 말합니다. 만성질환, 암 등 다양한 질병에 대한 노인의 취약성이 증가함에 따라 바이오마커에 의존한 조기 발견 및 모니터링의 필요성이 강조되고 있습니다. 예를 들어, 2022년 10월 스위스에 본부를 둔 국제 공중보건기구인 세계보건기구(WHO)가 발표한 보고서에 따르면, 2030년까지 전 세계 인구 6명 중 1명이 60세 이상이 될 것으로 예상되며, 2050년에는 60세 이상 노인 인구가 21억 명에 달할 것으로 예상되고 있습니다. 예상되고 있습니다. 따라서 노인 인구 증가가 바이오마커 시장의 성장을 견인하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나재난, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 바이오마커 시장 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
- 최종 이용 산업 분석
- 세계의 바이오마커 시장 성장률 분석
- 세계의 바이오마커 시장 실적 : 규모와 성장, 2019-2024년
- 세계의 바이오마커 시장 예측 : 규모와 성장, 2024-2029년, 2034년
- 세계 바이오마커 유효 시장(TAM)
제6장 시장 세분화
- 세계의 바이오마커 시장 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 폭로 바이오마커
- 질환 바이오마커
- 세계의 바이오마커 시장 : 기술별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 안전성 바이오마커
- 유효성 바이오마커
- 밸리데이션 바이오마커
- 세계의 바이오마커 시장 : 질환별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 신경질환
- 암
- 면역 질환
- 심혈관 질환
- 기타 질환
- 세계의 바이오마커 시장 : 청중별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 제약회사
- 정부 및 민간 연구기관
- 학술기관
- 의료기기 제조 회사
- 세계의 바이오마커 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 리스크 평가
- 분자진단 개발
- 질병 진단
- Drug Discovery & Development
- 약제 처방
- 법의학 용도
- 기타 용도(DNA 지문 검사 등)
- 세계의 바이오마커 시장 : 안전성 바이오마커 서브 세분화 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 독성 바이오마커
- 약물 동태 바이오마커
- 부작용 바이오마커
- 세계의 바이오마커 시장 : 유효성 바이오마커 서브 세분화 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 약역학 바이오마커
- 질환 진행 바이오마커
- 치료 반응성 바이오마커
- 세계의 바이오마커 시장 : 밸리데이션 바이오마커 서브 세분화 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 분석 밸리데이션 바이오마커
- 임상 밸리데이션 바이오마커
- Qualification Biomarkers
제7장 지역별/국가별 분석
- 세계의 바이오마커 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 세계의 바이오마커 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 바이오마커 시장 : 경쟁 구도
- 바이오마커 시장 : 기업 개요
- Enzo Biochem Inc
- Bio-Rad Laboratories Inc.
- Merck KGaA
- PerkinElmer Inc.
- QIAGEN N. V.
제31장 기타 주요 기업 및 혁신 기업
- Adaptive Biotechnologies Corp.
- Agilent Technologies Inc.
- Biocrates Life Sciences AG
- BioFire Diagnostics LLC
- BioReference Laboratories Inc.
- Bio-Techne Corporation
- Cepheid Inc.
- Eurofins Scientific SE
- Exact Sciences Corporation
- Foundation Medicine Inc.
- Genomic Health Inc.
- GenScript Biotech Corporation
- Guardant Health Inc.
- Illumina Inc.
- Invitae Corporation
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 시장의 최근 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 바이오마커 시장(2029년) - 가장 새로운 기회를 제공하는 국가
- 바이오마커 시장(2029년) - 가장 새로운 기회를 제공하는 부문
- 바이오마커 시장(2029년) - 성장 전략
제36장 부록
LSH
Biomarkers refer to a biological molecule that is a marker for a condition, disease, or aberrant process and can be discovered in tissues, body fluids, or blood. It is used to determine how well the body responds to a disease or condition's treatment. These biomarkers have a clinical role in narrowing or guiding treatment decisions.
The main types of biomarkers are biomarker of exposure and biomarker of diseases. The biomarker of exposure is a substance corresponding to the chemical that may be found in the body. When a person is exposed to chemicals by direct contact, inhaling or ingesting helps to identify them. Various technologies used for biomarker are safety biomarkers, efficacy biomarkers, and validation biomarkers used to treat diseases such as neurological diseases, cancer, immunological diseases, cardiovascular diseases, and other. These biomarker are used by pharmaceutical companies, government and private research institutes, academic institutes, and medical device manufacturing companies for risk assessment, the development of molecular diagnostic, disease diagnosis, drug discovery and development, drug formulation, forensic application and others (DNA fingerprinting, and others).
The biomarkers market research report is one of a series of new reports from The Business Research Company that provides biomarkers market statistics, including biomarkers industry global market size, regional shares, competitors with a biomarkers market share, detailed biomarkers market segments, market trends and opportunities, and any further data you may need to thrive in the biomarkers industry. This biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The biomarkers market size has grown rapidly in recent years. It will grow from $68.77 billion in 2024 to $78.14 billion in 2025 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to advancements in genomics and proteomics technologies, increasing prevalence of chronic diseases, growing emphasis on personalized medicine, rising demand for companion diagnostics, expansion of applications in drug development.
The biomarkers market size is expected to see rapid growth in the next few years. It will grow to $135.14 billion in 2029 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to growing focus on early disease detection and prevention, expansion of biomarkers in oncology and immunotherapy, increasing investment in precision medicine initiatives, rise of liquid biopsy as a non-invasive biomarker detection method, rising preference of biomarkers in drug discovery and development. Major trends in the forecast period include development of multi-biomarker panels, emergence of exosome-based biomarkers, adoption of point-of-care biomarker testing, integration of real-world data in biomarker research, exploration of microbiome-based biomarkers.
The increase in heart diseases is expected to propel the growth of the biomarkers market in the forecasted period. The use of biomarkers for heart disease patients has increased tremendously over the last few years. Currently, the natriuretic peptides are the most used biomarker and help in the diagnosis of patients with heart failure. Biomarkers such as circulating biomarkers with high sensitivity C-reactive protein are used for the diagnosis of heart failure. Heart disease is among leading cause of death for people of most racial and ethnic groups in the United States. The increase in heart diseases will drive the demand for biomarkers. For instance, in August 2022, according to a report published by the American College of Cardiology, a US-based non-profit medical association, In the United States, it is anticipated that all four cardiovascular risk factors will increase between 2025 and 2060. The largest percentage rise is expected in diabetes, with a 39. 3% increase to 55 million individuals, followed by dyslipidemia (27. 6% to 126 million), hypertension (25. 1% to 162 million), and obesity (18. 3% to 126 million). The researchers also observed that the most substantial projected increases in cardiovascular disease rates were for stroke (33. 8% to 15 million) and heart failure (33. 4% to 13 million), followed by ischemic heart disease (30. 7% to 29 million) and heart attack (16. 9% to 16 million). Because of the increase in heart diseases and heart deaths, there will be an increase in growth for the biomarkers.
The increase in the geriatric population is expected to boost the growth of the biomarker market going forward. The geriatric population refers to the percentage of people 65 and older to those between the ages of 18 and 64 who are employed. The elevated vulnerability of elderly individuals to various diseases, including chronic conditions and cancer, underscores the need for early detection and monitoring, often reliant on biomarkers. For instance, in October 2022, according to a report published by the World Health Organization (WHO), a Switzerland-based agency responsible for international public health, one in six people is expected to be 60 or older by the year 2030, in the entire world. By 2050, there will be 2. 1 billion people worldwide who are 60 years old or older. Therefore, the increase in the geriatric population is driving the growth of the biomarker market.
Major companies in the biomarker market are concentrating on creating innovative solutions, such as a novel biological marker, to drive innovation through collaborative research, technology integration, and robust clinical validation. A novel biological marker is a newly identified indicator that reflects biological processes and assists in diagnosing or monitoring diseases. It can take the form of a molecule, gene, or cellular characteristic, with potential implications for personalized medicine. For instance, in September 2024, Genialis, a US-based computational precision medicine company, introduced a first-in-class biomarker. This biomarker enhances predictive accuracy for patient responses to KRAS inhibitors, enabling the development of personalized treatment plans and improving clinical outcomes. Its wide-ranging application across various cancer types facilitates efficient drug development and optimizes patient selection for targeted therapies.
Major companies operating in the biomarker market are developing innovative products such as biomarker tests to meet larger customer bases, more sales, and increase revenue. Biomarker tests, also known as biomarker assays, are laboratory techniques or diagnostic tests that measure specific biological markers, which can include molecules, genes, proteins, or other substances, to provide information about various physiological or pathological processes in the body. For instance, in July 2023, Quest Diagnostics, a US-based medical laboratories company, launched a novel prostate cancer biomarker test. The newly introduced tissue-based test service aims to meet the urgent clinical demand for tests that can assist in distinguishing potentially aggressive cases of prostate cancer in males. Quest has created and validated this laboratory test through an intellectual property license agreement with Envision, allowing the utilization of Envision's exclusive biomarker and immunohistochemistry technology, incorporating Envision's distinct staining methods and innovative biomarkers referred to as EV1, EV2, and EV3.
In July 2023, Biocare Medical, a US-based biotechnology company, acquired Empire Genomics for an undisclosed amount. Through this acquisition, Biocare is broadening its molecular portfolio, encompassing more than 1 million biomarkers, and introducing swift biomarker development to advance cancer research leadership. Biocare Medical's expanded molecular menu, coupled with its state-of-the-art automation platforms such as the ONCORE Pro X, will empower researchers to accelerate their work, expediting cancer diagnostics for improved patient outcomes at an unprecedented pace. Empire Genomics is a US-based biotechnology company.
Major companies operating in the biomarkers market include Enzo Biochem Inc, Bio-Rad Laboratories Inc., Merck KGaA, PerkinElmer Inc., QIAGEN N. V., Adaptive Biotechnologies Corp., Agilent Technologies Inc., Biocrates Life Sciences AG, BioFire Diagnostics LLC, BioReference Laboratories Inc., Bio-Techne Corporation, Cepheid Inc., Eurofins Scientific SE, Exact Sciences Corporation, Foundation Medicine Inc., Genomic Health Inc., GenScript Biotech Corporation, Guardant Health Inc., Illumina Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Luminex Corporation, Metabolon Inc., Myriad Genetics Inc., Natera Inc., Pacific Biosciences of California Inc., Quest Diagnostics Incorporated, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Veracyte Inc.
North America was the largest region in the biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.
The biomarkers market consists of sales of molecular biomarkers, cellular biomarkers or imaging biomarkers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Biomarkers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on biomarkers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for biomarkers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biomarkers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Technology: Safety Biomarkers; Efficacy Biomarkers; Validation Biomarkers
- 2) By Disease: Neurological Diseases; Cancer; Immunological Diseases; Cardiovascular Diseases; Other Diseases
- 3) By Type: Biomarker Of Exposure; Biomarker Of Diseases
- 4) By Audiences: Pharmaceutical Companies; Government And Private Research Institutes; Academic Institutes; Medical Device Manufacturing Companies
- Subsegments:
- 1) By Safety Biomarkers: Toxicity Biomarkers; Pharmacokinetic Biomarkers; Adverse Effect Biomarkers
- 2) By Efficacy Biomarkers: Pharmacodynamic Biomarkers; Disease Progression Biomarkers; Treatment Response Biomarkers
- 3) By Validation Biomarkers: Analytical Validation Biomarkers; Clinical Validation Biomarkers; Qualification Biomarkers
- Companies Mentioned: Enzo Biochem Inc; Bio-Rad Laboratories Inc.; Merck KGaA; PerkinElmer Inc.; QIAGEN N. V.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Biomarkers Market Characteristics
3. Biomarkers Market Trends And Strategies
4. Biomarkers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Biomarkers Growth Analysis And Strategic Analysis Framework
- 5.1. Global Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Biomarkers Market Growth Rate Analysis
- 5.4. Global Biomarkers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Biomarkers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Biomarkers Total Addressable Market (TAM)
6. Biomarkers Market Segmentation
- 6.1. Global Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Biomarker Of Exposure
- Biomarker Of Diseases
- 6.2. Global Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Safety Biomarkers
- Efficacy Biomarkers
- Validation Biomarkers
- 6.3. Global Biomarkers Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Neurological Diseases
- Cancer
- Immunological Diseases
- Cardiovascular Diseases
- Other Diseases
- 6.4. Global Biomarkers Market, Segmentation By Audiences, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pharmaceutical Companies
- Government And Private Research Institutes
- Academic Institutes
- Medical Device Manufacturing Companies
- 6.5. Global Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Risk Assessment
- Development of Molecular Diagnostic
- Disease Diagnosis
- Drug Discovery And Development
- Drug Formulation
- Forensic Application
- Other Applications (DNA Fingerprinting And Others )
- 6.6. Global Biomarkers Market, Sub-Segmentation Of Safety Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Toxicity Biomarkers
- Pharmacokinetic Biomarkers
- Adverse Effect Biomarkers
- 6.7. Global Biomarkers Market, Sub-Segmentation Of Efficacy Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pharmacodynamic Biomarkers
- Disease Progression Biomarkers
- Treatment Response Biomarkers
- 6.8. Global Biomarkers Market, Sub-Segmentation Of Validation Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Analytical Validation Biomarkers
- Clinical Validation Biomarkers
- Qualification Biomarkers
7. Biomarkers Market Regional And Country Analysis
- 7.1. Global Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Biomarkers Market
- 8.1. Asia-Pacific Biomarkers Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Biomarkers Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Biomarkers Market
- 9.1. China Biomarkers Market Overview
- 9.2. China Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Biomarkers Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Biomarkers Market
- 10.1. India Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Biomarkers Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Biomarkers Market
- 11.1. Japan Biomarkers Market Overview
- 11.2. Japan Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Biomarkers Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Biomarkers Market
- 12.1. Australia Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Biomarkers Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Biomarkers Market
- 13.1. Indonesia Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Biomarkers Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Biomarkers Market
- 14.1. South Korea Biomarkers Market Overview
- 14.2. South Korea Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Biomarkers Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Biomarkers Market
- 15.1. Western Europe Biomarkers Market Overview
- 15.2. Western Europe Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Biomarkers Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Biomarkers Market
- 16.1. UK Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Biomarkers Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Biomarkers Market
- 17.1. Germany Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Biomarkers Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Biomarkers Market
- 18.1. France Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Biomarkers Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Biomarkers Market
- 19.1. Italy Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Biomarkers Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Biomarkers Market
- 20.1. Spain Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Biomarkers Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Biomarkers Market
- 21.1. Eastern Europe Biomarkers Market Overview
- 21.2. Eastern Europe Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Biomarkers Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Biomarkers Market
- 22.1. Russia Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Biomarkers Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Biomarkers Market
- 23.1. North America Biomarkers Market Overview
- 23.2. North America Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Biomarkers Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Biomarkers Market
- 24.1. USA Biomarkers Market Overview
- 24.2. USA Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Biomarkers Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Biomarkers Market
- 25.1. Canada Biomarkers Market Overview
- 25.2. Canada Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Biomarkers Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Biomarkers Market
- 26.1. South America Biomarkers Market Overview
- 26.2. South America Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Biomarkers Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Biomarkers Market
- 27.1. Brazil Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Biomarkers Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Biomarkers Market
- 28.1. Middle East Biomarkers Market Overview
- 28.2. Middle East Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Biomarkers Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Biomarkers Market
- 29.1. Africa Biomarkers Market Overview
- 29.2. Africa Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Biomarkers Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Biomarkers Market Competitive Landscape And Company Profiles
- 30.1. Biomarkers Market Competitive Landscape
- 30.2. Biomarkers Market Company Profiles
- 30.2.1. Enzo Biochem Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. QIAGEN N. V. Overview, Products and Services, Strategy and Financial Analysis
31. Biomarkers Market Other Major And Innovative Companies
- 31.1. Adaptive Biotechnologies Corp.
- 31.2. Agilent Technologies Inc.
- 31.3. Biocrates Life Sciences AG
- 31.4. BioFire Diagnostics LLC
- 31.5. BioReference Laboratories Inc.
- 31.6. Bio-Techne Corporation
- 31.7. Cepheid Inc.
- 31.8. Eurofins Scientific SE
- 31.9. Exact Sciences Corporation
- 31.10. Foundation Medicine Inc.
- 31.11. Genomic Health Inc.
- 31.12. GenScript Biotech Corporation
- 31.13. Guardant Health Inc.
- 31.14. Illumina Inc.
- 31.15. Invitae Corporation
32. Global Biomarkers Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Biomarkers Market
34. Recent Developments In The Biomarkers Market
35. Biomarkers Market High Potential Countries, Segments and Strategies
- 35.1 Biomarkers Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Biomarkers Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Biomarkers Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
